Patent application number | Description | Published |
20090030434 | Surgical Fasteners and Devices for Surgical Fasteners - The invention provides fasteners for surgical fastening. The surgical fastener of the invention has a crown from which extend two or more prongs. The prongs are parallel to the axis of the crown and each prong is provided with one or more barbs. The invention also provides a system for surgical fastening device configured to deploy one or more surgical fasteners of the invention and one or more surgical fasteners of the invention. | 01-29-2009 |
20090069876 | System and Method for thermally Treating Tissues - A system and method are provided for thermally treating tissues in percutaneous surgery or endoluminal treatments. The system consists of at least one catheter for thermally treating a tissue, hydraulic unit for circulating fluids through the catheters and a control station by which an operator is displayed with, and inputs and/or modifies, working parameters of the system. The catheters have an operational face, which is optionally expandable and encloses a lumen through which the fluids are circulated. The method disclosed implements cooling of the targeted tissue prior to its heating. For heating and or cooling the tissues, the operational face of a catheter is pressed against a surface of the targeted tissue while heat emitted from or conducted to the tissue is respectively transferred into or from the circulated fluids. | 03-12-2009 |
20090136462 | TUMOR ASSOCIATED ANTIGEN PEPTIDES AND USE OF SAME AS ANTI-TUMOR VACCINES - The present invention relates to tumor associated antigen (TAA) peptides and to use of same, of polynucleotides encoding same and of cells presenting same as anti-tumor vaccines. More particularly, the present invention relates to tumor associated antigen peptides derived from Uroplakin Ia, Ib, II and III, Prostate specific antigen (PSA), Prostate acid phosphatase (PAP) and Prostate specific membrane antigen (PSMA), BA-46 (Lactadherin), Mucin (MUC-1), and Teratocarcinoma-derived growth factor (CRIPTO-1) and the use of same as anti-tumor vaccines to prevent or cure bladder, prostate, breast or other cancers, carcinomas in particular. Most particularly, the present invention relates to tumor associated antigen peptides which are presentable to the immune system by HLA-A2 molecules. | 05-28-2009 |
20090254075 | Surgical Instrument - A surgical instrument suitable for endoscopic operations having a gripping handle, tubular body and an operational tip. Jetting outlets laterally disposed at the operational tip provides for jetting pressurized liquid delivered by the tubular body. The jetting outlets are configured as to emit converging jets. Two or more jets converge at a convergence point laterally displaced at a predefined distance from the surface of the operational tip. The operational tip includes a heating member having an active face for contact heating a bleeding tissue. A rotating mechanism provides for independently rotating the jetting outlets and the active surface of the heating member relative to the gripping handle. A method for regulating the operating temperature of the heating member is provided. | 10-08-2009 |
20090264900 | Extracting Device for Surgical Fasteners - The application provides a device ( | 10-22-2009 |
20100129410 | Methods and Immunogenic Cell Preparations for Treating Antigen-Associated Diseases - A method of inhibiting growth of, reducing or eliminating a cell population of a subject in need thereof is disclosed. The method comprises (a) thermally, mechanically and/or chemically damaging antigen-bearing cells which comprise at least one antigen characterizing cells of the cell population, with the proviso that the chemically damaging of the antigen-bearing cells is not predominantly effected using one or more antineoplastic agents, thereby generating immunogenic cells; and (b) introducing in the subject a cell aggregate which comprises the immunogenic cells and added antigen-presenting cells, thereby inducing an immune response for inhibiting growth of, reducing or eliminating the cell population of the subject. | 05-27-2010 |
20100130993 | Anastomosis device and system - An anastomosis device for forming two lumen-comprising body structures having an un-deployed and a deployed state and switchable from the former to the latter, comprising: a body with an overall cylindrical shape defining a proximal-distal extending axis of and comprising an external essentially cylindrical body part with a lumen and an internal body part at least a portion thereof being deployed within the lumen of the external body part and axially displacable with respect thereto in the switch between the un-deployed and the deployed states; said internal body part having an internal duct extending axially therethrough whereby in the deployed state there is a fluid communication between the distal and the proximal ends of the body; and two tissue-engaging units axially displaced from one another along said axis; at least one of the two units can change its state from a closed state in the un-deployed state of the device to an opened, tissue-engaging state in the deployed state of the device in which said first unit extends in an overall radial direction and is adapted in this state for tight association with internal walls of one of the body structures, such that the combined tissue-engaging action of the two unit holds the two structures together. | 05-27-2010 |
20100291127 | TUMOR ASSOCIATED ANTIGEN PEPTIDES AND USE OF SAME AS ANTI-TUMOR VACCINES - The present invention relates to tumor associated antigen (TAA) peptides and to use of same, of polynucleotides encoding same and of cells presenting same as anti-tumor vaccines. More particularly, the present invention relates to tumor associated antigen peptides derived from Uroplakin Ia, Ib, II and III, Prostate specific antigen (PSA), Prostate acid phosphatase (PAP) and Prostate specific membrane antigen (PSMA), BA-46 (Lactadherin), Mucin (MUC-1), and Teratocarcinoma-derived growth factor (CRIPTO-1) and the use of same as anti-tumor vaccines to prevent or cure bladder, prostate, breast or other cancers, carcinomas in particular. Most particularly, the present invention relates to tumor associated antigen peptides which are presentable to the immune system by HLA-A2 molecules. | 11-18-2010 |
20120253097 | DEVICE SYSTEM AND METHOD FOR TISSUE DISPLACEMENT OR SEPARATION - A tissue displacement/separation device is provided. The device includes a bladder which is expandable between a first tissue and a second tissue of a body. The bladder has an expanded shape which is selected capable of displacing or separating the first tissue from the second tissue in a manner suitable for protecting the first tissue from an effect of a treatment applied to the second tissue. | 10-04-2012 |